Our results revealed that ATG3, ATG4D, ATG4C, ATG4A, ATG2B, ATG5 expression was significantly higher in EBV-positive NPC compared to healthy controls, suggesting a notable role of EBV in modulating the levels of these genes. The gene discussed is ATG4D; the disease is nasopharyngeal carcinoma.